Axio Biosolutions Private Limited, a active private limited company, was established on 16 May 2008 in Ahmedabad, Gujarat, India. Engaging in medical consumables & supplies within the manufacturing sector, it holds CIN: U73100GJ2008PTC053905. Registered under ROC Roc Ahmedabad. it is unlisted. It has an authorized capital of ₹3.00 Cr and a paid-up capital of ₹2.71 Cr.
It upholds a compliant status. Employing 70 professional, Its leadership includes Gourav Jagdishchandra Maheshwari (Director), Leo Sebastian Mavely (Director). Past directors included Sebastian Joseph Mavely, Gourav Jagdishchandra Maheshwari, Arvind Modi. It holds ₹7.84 Cr open charges and ₹10.26 Cr settled loans. Its latest AGM occurred on 30 September 2024, with the balance sheet filed on 31 March 2024. It is based at Plot No 18, Gujarat Pharma Techno Park Sari-Motoda, Ta: Sanand, Ahmedabad, Gujarat, 382220.
U73100GJ2008PTC053905
053905
16 May 2008
₹3.00 Cr
₹2.71 Cr
Roc Ahmedabad
Unlisted
Active
Explore comprehensive insights into Axio Biosolutions Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Gourav Jagdishchandra Maheshwari | Director | 16 May 2018 | Current |
| Leo Sebastian Mavely | Director | 16 May 2008 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Director | 26 Aug 2019 | Past |
| Pramod Abcsdd | Additional Director | 28 Sep 2018 | Past |
| Pramod Abcsdd | Director | 21 Feb 2018 | Past |
| Pramod Abcsdd | Director | 18 May 2016 | Past |
| Pramod Abcsdd | Additional Director | 03 Aug 2015 | Past |
| Pramod Abcsdd | Director | 18 May 2016 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Axio Biosolutions Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 31.94% increase. The company also saw a substantial improvement in profitability, with a 39.42% increase in profit. The company's net worth observed a substantial decline by a decrease of 29.46%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
In 2023, Axio Biosolutions had a public holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
₹78,400,000.00
₹102,600,000.00
| Date | Lender | Amount | Status |
|---|---|---|---|
| 30 May 2023 | Others | ₹7.84 Cr | Satisfied |
| 18 Oct 2013 | Technology Development Board | ₹1.33 Cr | Satisfied |
| 28 Jun 2010 | Gvfl Trustee Company Private Limited | ₹1.09 Cr | Satisfied |
Explore comprehensive loan charge details -
Axio Biosolutions has a workforce of 70 employees as of Feb 24, 2025. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Gain comprehensive insights into the Deals and Valuation data of Axio Biosolutions, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Axio Biosolutions's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
The activity A charge registered on 30 May 2023 via Charge ID 100727750 with Others was fully satisfied on 05 Jul 2025. was completed.
Progress on Axio Biosolutions Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records. was documented.
The activity Axio Biosolutions Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Ahmedabad. was completed.
A charge with Others amounted to Rs. 7.84 Cr with Charge ID 100727750 was registered on 30 May 2023. was recorded as a recent event.
The activity Gourav Jagdishchandra Maheshwari was appointed as a Director was appointed as a Director on 16 May 2018 & has been associated with this company since 7 years 7 months . was completed.
The activity A charge registered on 28 Jun 2010 via Charge ID 10227078 with Gvfl Trustee Company Private Limited was fully satisfied on 02 Sep 2015. was completed.
The bleeding control kit is specially designed to upgrade the conventional first aid kits available with the BFNAs, armoured vehicles, aircraft jets, submarines Axio Biosolutions showcased its flagshi.
Ax-surgi becomes the first and only chitosan-based hemostat cleared for controlling severe surgical bleeding Axio Biosolutions, a biomaterial focussed medtech company, announced the US Food and Drug A.
The CIN of Axio Biosolutions Private Limited is U73100GJ2008PTC053905.
Axio Biosolutions Private Limited is headquartered at Plot No 18, Gujarat Pharma Techno Park Sari-Motoda, Ta: Sanand, Ahmedabad, Gujarat, 382220.
Axio Biosolutions Private Limited was incorporated on 16 May 2008.
The current directors of Axio Biosolutions Private Limited are
The primary industry of Axio Biosolutions Private Limited is Manufacturing.
Axio Biosolutions Private Limited is unlisted.
The authorized capital of Axio Biosolutions Private Limited is ₹3.00 Cr, and the paid-up capital is ₹2.71 Cr.
The compliance status of Axio Biosolutions Private Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX